Samsung Electronics Switzerland has teamed up with Bottneuro AG, a Swiss MedTech startup, to develop a ground-breaking solution for the diagnosis and treatment of Alzheimer’s disease. This innovative technology uses 3D magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging data to identify affected areas of the brain, which can then be targeted with Miamind® neurostimulator technology, a non-invasive treatment that has been shown to improve cognitive function in patients.
Alzheimer’s disease affects over 50 million people worldwide and is a progressive disease that causes memory loss, cognitive decline, and eventually, the inability to perform even basic tasks. The partnership between Samsung and Bottneuro AG is aimed at improving the quality of life for patients suffering from this debilitating condition.
Bottneuro AG’s innovative approach to Alzheimer’s treatment is based on a comprehensive understanding of the disease and its progression. The company’s technology identifies areas of the brain affected by the disease and targets them with Miamind® neurostimulator technology. This non-invasive treatment has been shown to improve cognitive function in patients.
The Galaxy Tab S8+ 5G Enterprise Edition is used to store and record therapy data in the Bottneuro Solution, making it easier for patients to manage their treatment. This tablet has an intuitive interface and usability that is easy for patients to operate and understand. Patients who suffer from dementia often experience reduced cognitive function in the early stages of the disease, making the need for finding a device that is easy to operate and understand imperative for Bottneuro AG.
In addition to providing a reliable and safe solution, Samsung Knox can be used to individually configure the Galaxy Tab S8+ 5G Enterprise Edition, keeping sensitive data and medical records private and protected.
“We were looking for a simple and reliable solution for our application. We found it with the Galaxy Tab S8+ 5G Enterprise Edition, and Samsung is giving us great support in the development,” said Julius Klaas, CTO of Bottneuro AG.